Literature DB >> 30742712

Marginal false discovery rate control for likelihood-based penalized regression models.

Ryan E Miller1, Patrick Breheny1.   

Abstract

The popularity of penalized regression in high-dimensional data analysis has led to a demand for new inferential tools for these models. False discovery rate control is widely used in high-dimensional hypothesis testing, but has only recently been considered in the context of penalized regression. Almost all of this work, however, has focused on lasso-penalized linear regression. In this paper, we derive a general method for controlling the marginal false discovery rate that can be applied to any penalized likelihood-based model, such as logistic regression and Cox regression. Our approach is fast, flexible and can be used with a variety of penalty functions including lasso, elastic net, MCP, and MNet. We derive theoretical results under which the proposed method is valid, and use simulation studies to demonstrate that the approach is reasonably robust, albeit slightly conservative, when these assumptions are violated. Despite being conservative, we show that our method often offers more power to select causally important features than existing approaches. Finally, the practical utility of the method is demonstrated on gene expression datasets with binary and time-to-event outcomes.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cox regression; false discovery rates; generalized linear models; high-dimensional data analysis; lasso; penalized regression

Mesh:

Year:  2019        PMID: 30742712     DOI: 10.1002/bimj.201800138

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  5 in total

1.  Marginal false discovery rate for a penalized transformation survival model.

Authors:  Weijuan Liang; Shuangge Ma; Cunjie Lin
Journal:  Comput Stat Data Anal       Date:  2021-04-02       Impact factor: 2.035

2.  The Doubled-Edged Sword of T1-Mapping in Systemic Sclerosis-A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance.

Authors:  George Markousis-Mavrogenis; Loukia Koutsogeorgopoulou; Gikas Katsifis; Theodoros Dimitroulas; Genovefa Kolovou; George D Kitas; Petros P Sfikakis; Sophie I Mavrogeni
Journal:  Diagnostics (Basel)       Date:  2020-05-24

3.  Cardiovascular magnetic resonance clarifies arrhythmogenicity in asymptomatic young athletes with ventricular arrhythmias undergoing pre-participation evaluation.

Authors:  George Markousis-Mavrogenis; Aikaterini Giannakopoulou; Nikolaos Andreou; George Papadopoulos; Vasiliki Vartela; Genovefa Kolovou; Flora Bacopoulou; Konstantinos Tsarouhas; Christina Kanaka-Gantenbein; Demetrios A Spandidos; Sophie I Mavrogeni
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

4.  Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-sectional Study.

Authors:  George Markousis-Mavrogenis; Dimos D Mitsikostas; Loukia Koutsogeorgopoulou; Theodoros Dimitroulas; Gikas Katsifis; Panayiotis Argyriou; Dimitrios Apostolou; Stella Velitsista; Vasiliki Vartela; Dionysia Manolopoulou; Maria G Tektonidou; Genovefa Kolovou; George D Kitas; Petros P Sfikakis; Sophie I Mavrogeni
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241

5.  The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.

Authors:  Zeyu Wang; Yuze Liu; Yuyao Mo; Hao Zhang; Ziyu Dai; Xun Zhang; Weijie Ye; Hui Cao; Zhixiong Liu; Quan Cheng
Journal:  Front Immunol       Date:  2021-09-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.